Skip to main content
Article
Percutaneous needle biopsy of musculoskeletal lesions. 2. Cost-effectiveness
American Journal of Roentgenology
  • Margaret A. Fraser-Hill, University of Iowa
  • Donald L. Renfrew, University of Iowa
  • Peter E. Hilsenrath, University of Iowa
Document Type
Article
DOI
10.2214/ajr.158.4.1546598
Publication Date
1-4-1992
Abstract

We compared the cost-effectiveness of fluoroscopically directed percutaneous needle biopsy (PNB) of musculoskeletal lesions, CT-guided PNB, and open biopsy. We independently assessed the following characteristics: suspected lesion type (metastatic deposit, infection, or primary neoplasm, as determined by clinical findings and radiologic appearance before biopsy); lesion location (axial or appendicular); and appearance on plain films (radiolucent or lytic, sclerotic, vertebral compression fracture, and soft-tissue lesions). In suspected primary tumors, cost-effectiveness of PNB was similar to that of open biopsy: fluoroscopically directed PNB was slightly more cost-effective than open biopsy whereas CT-directed PNB was slightly less cost-effective. Either type of PNB was cost-effective for suspected metastatic deposits and infections, axial and appendicular lesions, radiolucent or lytic lesions, and soft-tissue lesions. We conclude that PNB is cost-effective for most musculoskeletal lesions.

Citation Information
Margaret A. Fraser-Hill, Donald L. Renfrew and Peter E. Hilsenrath. "Percutaneous needle biopsy of musculoskeletal lesions. 2. Cost-effectiveness" American Journal of Roentgenology Vol. 158 Iss. 4 (1992) p. 813 - 818 ISSN: 0361-803X
Available at: http://works.bepress.com/peter-hilsenrath/216/